Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration

被引:35
|
作者
Imfeld-Isenegger, Tamara Leila [1 ]
Soares, Ines Branco [2 ]
Makovec, Urska Nabergoj [3 ]
Horvat, Nejc [3 ]
Kos, Mitja [3 ]
van Mil, Foppe [4 ]
Costa, Filipa A. [2 ]
Hersberger, Kurt E. [1 ]
机构
[1] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[2] IUEM, CiiEM, Campus Univ, P-2829511 Monte De Caparica, Caparica, Portugal
[3] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
[4] Von Mil Consultancy, Margrietlaan 1, NL-9471 CT Zuidlaren, Netherlands
来源
关键词
Medication review; Community pharmacy services; Primary health care; Service implementation; Remuneration; Europe; DRUG-RELATED PROBLEMS; FOLLOW-UP SERVICE; PHARMACEUTICAL CARE; THERAPY MANAGEMENT; POLYPHARMACY; TERMINOLOGY; ELIGIBILITY;
D O I
10.1016/j.sapharm.2019.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Pharmaceutical Care Network Europe (PCNE) proposed a definition and classification system (type 1, 2a, 2b, 3) for medication review in 2016. However, to date, a description of the implementation and remuneration of such procedures across Europe is lacking. Objective: The aim of this study was to describe the medication review procedures and the level of implementation and remuneration in community pharmacies across Europe. Methods: An online survey was developed to characterize medication review procedures (PCNE classification), level of implementation (considering regional or national) and remuneration by a third party. This survey was sent to a purposive sample of three individuals per country, with a working background in community pharmacy, pharmacy practice research, or health policy to ensure reliable data. Data triangulation was used and consensus sought between the responses. Results: Data were received from 34 out of 44 targeted European countries (November 2016-October 2017) [response rate = 77%]. Overall, 55.9% of the countries provided at least one type of medication review as an implemented service or project. Type 1 medication review (based on the medication history) was provided in 13 countries, type 2a (medication history + patient interview) in 14, type 2b (medication history + clinical data) in two, and type 3 medication review (medication history + patient interview + clinical data) in four countries. Ten of the mentioned services or projects were remunerated by a third-party. Conclusion: Substantial heterogeneity was observed across Europe in various aspects, including the procedures, implementation level and remuneration obtained. Type 1 and 2a medication review services seem to be more feasible to implement in the community pharmacy than type 2b and 3. A large number of medication review projects were ongoing in community pharmacies, which suggests that new medication review services could become implemented in the coming years.
引用
收藏
页码:1057 / 1066
页数:10
相关论文
共 50 条
  • [1] Implementation of Pharmacist-led Antithrombotic Medication Management for Elective Endoscopic Procedures
    Han, Henry
    Sippola, Emily
    Chen, Wilson
    Morgan, Spencer
    Renner, Elizabeth
    Ruff, Allison
    Sales, Anne
    Kurlander, Jacob
    Barnes, Geoffrey D.
    CIRCULATION, 2020, 142
  • [2] A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe
    Soares, Ines Branco
    Imfeld-Isenegger, Tamara L.
    Makovec, Urska Nabergoj
    Horvat, Nejc
    Kos, Mitja
    Arnet, Isabell
    Hersberger, Kurt E.
    Costa, Filipa A.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (01): : 41 - 47
  • [3] Exploring the heterogeneity in community pharmacist-led medication review studies - A systematic review
    Vogt, Cathrin J.
    Moecker, Robert
    Jacke, Christian O.
    Haefeli, Walter E.
    Seidling, Hanna M.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2024, 20 (08): : 679 - 688
  • [4] Pharmacist-led medication review in community settings: An overview of systematic reviews
    Jokanovic, Natali
    Tan, Edwin C. K.
    Sudhakaran, Sreeja
    Kirkpatrick, Carl M.
    Dooley, Michael J.
    Ryan-Atwood, Taliesin E.
    Bell, J. Simon
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2017, 13 (04): : 661 - 685
  • [5] Clinical pharmacist-led medication review in elderly patients at community pharmacy
    Dal, S.
    Ucar, N.
    Altiparmak, O.
    Sancar, M.
    Okuyan, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2020, 42 (01) : 242 - 242
  • [6] Implementation of pharmacist-led medication reviews in general practice
    Justin P. Turner
    J. Simon Bell
    International Journal of Clinical Pharmacy, 2013, 35 : 3 - 4
  • [7] Implementation of pharmacist-led medication reviews in general practice
    Turner, Justin P.
    Bell, J. Simon
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (01) : 3 - 4
  • [8] A pharmacist-led medication review service with a deprescribing focus guided by implementation science
    Eddine, Nada Alaa
    Schreiber, James
    El-Yazbi, Ahmed F.
    Shmaytilli, Haya
    Amin, Mohamed Ezzat Khamis
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Pharmacist-led discharge medication counselling: A scoping review
    Bonetti, Aline F.
    Reis, Walleri C.
    Lombardi, Natalia Fracaro
    Mendes, Antonio M.
    Netto, Harli Pasquini
    Rotta, Inajara
    Fernandez-Llimos, Fernando
    Pontarolo, Roberto
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2018, 24 (03) : 570 - 579
  • [10] Pharmacist-led medication review: response to Silcock & Petty
    Holland, Richard
    Loke, Yoon K.
    Desborough, James
    Wright, David
    Hall, Sandra
    Goodyer, Larry
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (04) : 576 - 576